Make Better Portfolio Decisions through Predictive Analytics
Global Practice Leader, Portfolio & Licensing
Competitive Intelligence & Clinical Product Director, Life Sciences
Numerous studies have analyzed R&D productivity and measured drug approval rates, but an analysis focused on success rates has limitations, providing only one piece to the puzzle.
In this webinar, Clarivate Analytics’ experts look at the dynamics of drug development a different way, using gold standard Cortellis content, innovative predictive modeling and powerful Centre for Medicines Research (CMR) data to help companies learn from the industry’s failures as well as its successes to improve R&D productivity.